by University of Texas Health Science Center at San Antonio ... Medicine and the Graduate School of Biomedical Sciences of UT Health San Antonio.
News
- Team discovers novel root cause of tau-induced neurodegeneration - Medical Xpress
- VelocityTX names new CEO as TRTF focuses on East SA campus expansion - San Antonio ...
Senior Reporter, San Antonio Business Journal ... team to help expand the campus and its connectivity with high-growth bioscience companies.
- BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
... first presented at the San Antonio Breast Cancer Symposium in December 2021 ... BriaCell is an immuno-oncology focused biotechnology company ...
- Scripps Health and UT Health San Antonio purchase Oncora's software to improve ... - Benzinga
PHILADELPHIA, April 13, 2022 /PRNewswire/ -- Oncora Medical (Oncora) announced today that Scripps Health (Scripps) and UT Health San Antonio (UT ...
- Scripps Health and UT Health San Antonio purchase Oncora's software to improve ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Thomas Heineman, M.D., Ph.D., the Company's Chief Medical Officer, will ...